Autoinjectors Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Autoinjectors Market
1.1. Definition and Scope
1.1.1. Definition of Autoinjectors
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Autoinjectors Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Autoinjectors Market By Therapy
1.2.3. Autoinjectors Market By Usage Type
1.2.4. Autoinjectors Market By Route of Administration
1.2.5. Autoinjectors Market By End-User
1.2.6. Autoinjectors Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Autoinjectors Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Autoinjectors Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Autoinjectors Market By Therapy
5.1. Introduction
5.2. Autoinjectors Revenue By Therapy
5.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Therapy, 2020-2032
5.2.2. Rheumatoid Arthritis
5.2.2.1. Rheumatoid Arthritis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Multiple Sclerosis
5.2.3.1. Multiple Sclerosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Diabetes
5.2.4.1. Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Anaphylaxis
5.2.5.1. Anaphylaxis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Other Therapies
5.2.6.1. Other Therapies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Autoinjectors Market By Usage Type
6.1. Introduction
6.2. Autoinjectors Revenue By Usage Type
6.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Usage Type, 2020-2032
6.2.2. Disposable Autoinjectors
6.2.2.1. Disposable Autoinjectors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Reusable Autoinjectors
6.2.3.1. Reusable Autoinjectors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Autoinjectors Market By Route of Administration
7.1. Introduction
7.2. Autoinjectors Revenue By Route of Administration
7.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By Route of Administration, 2020-2032
7.2.2. Subcutaneous
7.2.2.1. Subcutaneous Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Intramuscular
7.2.3.1. Intramuscular Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Autoinjectors Market By End-User
8.1. Introduction
8.2. Autoinjectors Revenue By End-User
8.2.1. Autoinjectors Revenue (USD Billion) and Forecast, By End-User, 2020-2032
8.2.2. Home Care Settings
8.2.2.1. Home Care Settings Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Hospitals & Clinics
8.2.3.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Ambulatory Surgical Centers
8.2.4.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Autoinjectors Market By Country
9.1. North America Autoinjectors Market Overview
9.2. U.S.
9.2.1. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.2.2. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
9.2.3. U.S. Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.2.4. U.S. Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.3.2. Canada Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
9.3.3. Canada Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.3.4. Canada Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Autoinjectors Market By Country
10.1. Europe Autoinjectors Market Overview
10.2. U.K.
10.2.1. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.2.2. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.2.3. U.K. Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.2.4. U.K. Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.3.2. Germany Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.3.3. Germany Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.3.4. Germany Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.4.2. France Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.4.3. France Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.4.4. France Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.5.2. Spain Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.5.3. Spain Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.5.4. Spain Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.6.2. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
10.6.3. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.6.4. Rest of Europe Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Autoinjectors Market By Country
11.1. Asia Pacific Autoinjectors Market Overview
11.2. China
11.2.1. China Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.2.2. China Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.2.3. China Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.2.4. China Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.3.2. Japan Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.3.3. Japan Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.3.4. Japan Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.4.2. India Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.4.3. India Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.4.4. India Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.5.2. Australia Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.5.3. Australia Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.5.4. Australia Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.6.2. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.6.3. South Korea Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.6.4. South Korea Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
11.7.2. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
11.7.3. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.7.4. Rest of Asia-Pacific Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Autoinjectors Market By Country
12.1. Latin America Autoinjectors Market Overview
12.2. Brazil
12.2.1. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
12.2.2. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
12.2.3. Brazil Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.2.4. Brazil Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
12.3.2. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
12.3.3. Mexico Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.3.4. Mexico Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
12.4.2. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
12.4.3. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.4.4. Rest of Latin America Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Autoinjectors Market By Country
13.1. Middle East & Africa Autoinjectors Market Overview
13.2. GCC
13.2.1. GCC Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
13.2.2. GCC Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
13.2.3. GCC Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.2.4. GCC Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
13.3.2. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
13.3.3. South Africa Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.3.4. South Africa Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Therapy, 2020-2032
13.4.2. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Usage Type, 2020-2032
13.4.3. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
13.4.4. Rest of Middle East & Africa Autoinjectors Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Autoinjectors Market
14.1. Autoinjectors Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Autoinjectors Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. AbbVie, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. AbbVie, Inc. 2022 Autoinjectors Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Amgen
15.3. Biogen Idec
15.4. Eli Lilly
15.5. Johnson & Johnson
15.6. Mylan N.V.
15.7. Owen Mumford
15.8. Pfizer, Inc.
15.9. Sanofi
15.10. Scandinavian Health Ltd.
15.11. Teva Pharmaceutical
15.12. Ypsomed
Frequently Asked Questions
What was the market size of the global autoinjectors in 2022?
The market size of autoinjectors was USD 51.3 Billion in 2022.
What is the CAGR of the global autoinjectors market from 2023 to 2032?
The CAGR of autoinjectors is 17.4% during the analysis period of 2023 to 2032.
Which are the key players in the autoinjectors market?
The key players operating in the global market are including AbbVie, Inc., Amgen, Biogen Idec, Eli Lilly, Johnson & Johnson, Mylan N.V., Owen Mumford, Pfizer, Inc., Sanofi, Scandinavian Health Ltd., Teva Pharmaceutical, Ypsomed, and others.
Which region dominated the global autoinjectors market share?
North America held the dominating position in autoinjectors industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of autoinjectors during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global autoinjectors industry?
The current trends and dynamics in the autoinjectors industry include benefits of autoinjectors in emergency medical care, rising incidence of diabetes and anaphylaxis, and patients preference to choose self-administration of injections.
Which usage type held the maximum share in 2022?
The disposable autoinjectors usage type held the maximum share of the autoinjectors industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
